Immunotherapies for malignant glioma


Glioblastoma multiforme (GBM) is a highly malignant primary brain cancer with a dreadful overall survival and for which treatment options are limited. Recent breakthroughs in novel immune-related treatment strategies for cancer have spurred interests in usurping the power of the patient’s immune system to recognize and eliminate GBM. Here, we discuss the… (More)
DOI: 10.1038/s41388-017-0024-z


2 Figures and Tables

Slides referencing similar topics